Zann(ZNNC)
$0.000.00 (0.00%)
ZNNC
Zann financials statements
$0.00
At close:0.00 (0.00%)
Zann (ZNNC) Ratios
1 Followers
Zann Ratios
ZNNC's free cash flow for Q? was ―. For the fiscal year, ZNNC's free cash flow was increased by ― and operating cash flow was ―. See a summary of the company’s cash flow.
| Ratios | Dec 22 | Dec 21 | Dec 20 |
|---|---|---|---|
| Liquidity Ratios | |||
| Current Ratio | 1.59 | 1.03 | 1.09 |
| Quick Ratio | 1.59 | 1.03 | 1.09 |
| Cash Ratio | 0.57 | 0.01 | 0.00 |
| Solvency Ratio | -0.00 | -0.07 | 0.02 |
| Operating Cash Flow Ratio | 0.02 | -1.13 | -0.22 |
| Short-Term Operating Cash Flow Coverage | 0.02 | -1.13 | -0.22 |
| Net Current Asset Value | $ -5.34M | $ -4.25M | $ -4.12M |
| Leverage Ratios | |||
| Debt-to-Assets Ratio | 2.42 | 6.88 | 5.84 |
| Debt-to-Equity Ratio | -1.28 | -0.86 | -0.84 |
| Debt-to-Capital Ratio | 4.63 | -5.94 | -5.10 |
| Long-Term Debt-to-Capital Ratio | 6.83 | -2.93 | -2.44 |
| Financial Leverage Ratio | -0.53 | -0.12 | -0.14 |
| Debt Service Coverage Ratio | -0.05 | -0.66 | -0.17 |
| Interest Coverage Ratio | 2.92 | -54.02 | -4.15 |
| Debt to Market Cap | 54.05 | 14.54 | 12.69 |
| Interest Debt Per Share | 0.15 | 0.11 | 0.10 |
| Net Debt to EBITDA | -250.32 | -11.55 | -38.30 |
| Profitability Margins | |||
| Gross Profit Margin | 95.35% | 0.00% | 0.00% |
| EBIT Margin | -12.63% | 0.00% | 0.00% |
| EBITDA Margin | -0.97% | 0.00% | 0.00% |
| Operating Profit Margin | 0.81% | 0.00% | 0.00% |
| Pretax Profit Margin | -12.91% | 0.00% | 0.00% |
| Net Profit Margin | -12.98% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | -12.98% | 0.00% | 0.00% |
| Net Income Per EBT | 100.55% | 100.00% | 100.00% |
| EBT Per EBIT | -1599.96% | 101.48% | 124.10% |
| Return on Assets (ROA) | -12.30% | -106.54% | -18.94% |
| Return on Equity (ROE) | 6.49% | 13.26% | 2.71% |
| Return on Capital Employed (ROCE) | 0.95% | -958.09% | -132.27% |
| Return on Invested Capital (ROIC) | 0.77% | -105.31% | -15.26% |
| Return on Tangible Assets | -12.30% | -106.54% | -19.67% |
| Earnings Yield | -275.05% | -225.31% | -41.11% |
| Efficiency Ratios | |||
| Receivables Turnover | 4.72 | 0.00 | 0.00 |
| Payables Turnover | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.95 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 15.32 | 0.00 | 0.00 |
| Cash Conversion Cycle | 77.34 | 0.00 | 0.00 |
| Days of Sales Outstanding | 77.34 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 0.00 | 0.00 |
| Operating Cycle | 77.34 | 0.00 | 0.00 |
| Cash Flow Ratios | |||
| Operating Cash Flow Per Share | 0.00 | -0.02 | -0.00 |
| Free Cash Flow Per Share | 0.00 | -0.02 | -0.00 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | -21.40 | -5.39 |
| Capital Expenditure Coverage Ratio | 0.00 | -21.40 | -5.39 |
| Operating Cash Flow Coverage Ratio | 0.00 | -0.15 | -0.03 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | 9.73% | -222.15% | -49.90% |
| Valuation Ratios | |||
| Price-to-Earnings (P/E) Ratio | -0.36 | -0.44 | -2.43 |
| Price-to-Sales (P/S) Ratio | 0.05 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | -0.02 | -0.06 | -0.07 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 10.27 | -0.45 | -2.00 |
| Price-to-Operating Cash Flow Ratio | 10.27 | -0.47 | -2.38 |
| Price-to-Earnings Growth (PEG) Ratio | 0.01 | -0.00 | 0.00 |
| Enterprise Value Multiple | -255.18 | -12.35 | -41.32 |
| Enterprise Value | 4.86M | 3.85M | 3.70M |
| EV to EBITDA | -255.18 | -12.35 | -41.32 |
| EV to Sales | 2.48 | 0.00 | 0.00 |
| EV to Free Cash Flow | 539.67 | -6.99 | -27.43 |
| EV to Operating Cash Flow | 539.55 | -7.31 | -32.52 |
| Tangible Book Value Per Share | -0.12 | -0.12 | -0.12 |
| Shareholders’ Equity Per Share | -0.12 | -0.12 | -0.12 |
| Tax and Other Ratios | |||
| Effective Tax Rate | -0.01 | 0.00 | 0.00 |
| Revenue Per Share | 0.06 | 0.00 | 0.00 |
| Net Income Per Share | -0.01 | -0.02 | -0.00 |
| Tax Burden | 1.01 | 1.00 | 1.00 |
| Interest Burden | 1.02 | 1.02 | 1.24 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 |
| Income Quality | -0.04 | 0.94 | 1.02 |
Currency in USD

